Evidence map›Paper›PMID 30691109›Full record

ArticleMolecules (Basel, Switzerland)2019

Structurally Simple Phenanthridine Analogues Based on Nitidine and Their Antitumor Activities.

Shu-Qin Qin, Lian-Chun Li, Jing-Ru Song, Hai-Yun Li, Dian-Peng Li

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shu-Qin QinGuangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, Guangxi, China. shuqinshu@163.com.ORCID 0000-0003-1157-8126
Lian-Chun LiGuangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, Guangxi, China. 15577498821@163.com.
Jing-Ru SongGuangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, Guangxi, China. songjingru@iccas.ac.cn.
Hai-Yun LiCollege of Chemistry and Bioengineering, Guilin University of Technology, Guilin 541006, Guangxi, China. lihaiyun@glut.edu.cn.
Dian-Peng LiGuangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, Guangxi, China. ldp@gxib.cn.

Funding

1. National Natural Science Foundation of China (No. 21602038); 2. Fundamental Research Fund of Guangxi Institute of Botany (16002); 3. the Director of Capital Program of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization (ZRJJ20 1. No: 21602038; 2. No:16002; 3. No: ZRJJ2016-2
6 · The paper itself

Abstract

A series of novel structurally simple analogues based on nitidine was designed and synthesized in search of potent anticancer agents. The antitumor activity against human cancer cell lines (HepG2, A549, NCI-H460, and CNE1) was performed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay in vitro. The results showed that some of them had good anticancer activities, especially derivatives with a [(dimethylamino)ethyl]amino side chain in the C-6 position. Planar conjugated compounds

Indexed as

Antineoplastic AgentsBenzophenanthridinesCell Line, TumorDose-Response Relationship, DrugHumansInhibitory Concentration 50PhenanthridinesStructure-Activity RelationshipAntineoplastic AgentsBenzophenanthridinesnitidinePhenanthridinesantitumor activitynitidinephenanthridinephenanthridinone

Identifiers

PMID30691109
PMCPMC6385102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.